Benefit category designation and payment determination expands patient access to the only FDA-cleared non-invasive targeted therapy for hand tremorSAN MATEO, Calif.--(BUSINESS WIRE)--Cala, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced that the Centers f...